Fidelity Investments
MRNS

Fidelity Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Fidelity Investments’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,751
Closed -$11.9K – 5924
2024
Q3 		$11.9K Sell
6,751
-3,953
-37% -$5.52K ﹤0.01% 4375
2024
Q2 		$12.5K Buy
10,704
+7,781
+266% +$19.5K ﹤0.01% 4252
2024
Q1 		$26.4K Buy
2,923
+479
+20% +$4.66K ﹤0.01% 3894
2023
Q4 		$26.6K Sell
2,444
-2,097
-46% -$15.7K ﹤0.01% 3802
2023
Q3 		$36.6K Buy
4,541
+122
+3% +$1.01K ﹤0.01% 3510
2023
Q2 		$48K Sell
4,419
-14
-0.3% -$120 ﹤0.01% 3453
2023
Q1 		$30.6K Buy
4,433
+4,210
+1,888% +$26.4K ﹤0.01% 3654
2022
Q4 		$888 Sell
223
-250,644
-100% -$1.23M ﹤0.01% 4678
2022
Q3 		$1.67M Sell
250,867
-228
-0.1% -$1.4K ﹤0.01% 2476
2022
Q2 		$1.22M Sell
251,095
-62,187
-20% -$378K ﹤0.01% 2624
2022
Q1 		$2.93M Sell
313,282
-97,883
-24% -$972K ﹤0.01% 2501
2021
Q4 		$4.88M Sell
411,165
-63,625
-13% -$735K ﹤0.01% 2371
2021
Q3 		$5.4M Buy
474,790
+25
+0% +$344 ﹤0.01% 2343
2021
Q2 		$8.52M Hold
474,765
– – ﹤0.01% 2171
2021
Q1 		$7.35M Hold
474,765
– – ﹤0.01% 2144
2020
Q4 		$5.79M Buy
474,765
+142,857
+43% +$1.99M ﹤0.01% 2143
2020
Q3 		$4.26M Hold
331,908
– – ﹤0.01% 2117
2020
Q2 		$3.37M Buy
+331,908
New +$3.05M ﹤0.01% 2164
2020
Q1 		– Hold
0
– – – 4361
2019
Q4 		– Hold
0
– – – 4355

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments's MRNS Position: Q4 2024 in Review

Fidelity Investments sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 6,751 shares — an estimated $11.9K sold.

Fidelity Investments first reported a position in MRNS in Q2 2020 and held it in 18 quarters. The position peaked at $8.52M in Q2 2021. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Fidelity Investments reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Fidelity Investments sold 6,751 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $11.9K.
  • Fidelity Investments first reported a position in Marinus Pharmaceuticals, Inc in Q2 2020 and held it in 18 quarters.
  • Fidelity Investments's Marinus Pharmaceuticals, Inc position peaked at $8.52M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.